Dusevic & Garcha has settled the within certified multi-jurisdictional product liability class proceeding which involved allegations that the Plaintiff and all resident persons in Canada, excluding the Province of Quebec, who purchased, acquired or ingested the prescription drugs, Cipro, Avelox and/or Levaquin, fluoroquinolone antibiotics which were designed, tested, developed, manufactured, labeled, packaged, marketed, promoted, advertised, licensed, sold and/or distributed, or otherwise placed into the stream of commerce, by the Defendants in Canada, excluding the Province of Quebec (“Class Members”) suffered peripheral neuropathy from ingesting the prescription drugs Cipro, Avelox and/or Levaquin.